Enrolling
Engagement and Retention
Co-infections and Related Conditions (CRC)
Filter By:
Reporting
CTN 307: ECF/TAF Switch in opioid substitution therapy
Evaluation of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (ECF/TAF) Switch followed by Sofosbuvir/Velpatasvir (SOF/VEL) Antiviral HCV Therapy in HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy — A Pilot Feasibility Study
Learn MoreCompleted
CTN 302: Visioning Health II
Indigenous, participatory evaluation and assessment of a culturally-grounded and arts-informed intervention for HIV-positive Aboriginal women
Learn MoreStart-up
CTN 301-2: DRUM and SASH Urban-Rural Sub-Study
Contextual Analysis of Urban and Rural Programs and Supports for First Nations and Métis People Living with HIV and other STBBIs
Learn MoreReporting
CTN 301: DRUM
Development of a Rural Model (DRUM) for Integrated Shared Care in First Nation and Métis Communities
Learn MoreReporting
CTN 298: Effect of human growth hormone on HIV reservoir
A proof-of-concept study to assess the effect of recombinant human growth hormone on the size of the replication-competent viral reservoir in HIV-infected individuals on suppressive ART
Learn MoreReporting
CTN 294: The LAGHDA Study
Longitudinal Analysis of HIV Genetic Diversification under Antiretroviral therapy (LAHGDA)
Learn MoreCompleted
CTN 289: E/C/F/TAF switch with ledipasivir-sofosbuvir therapy
Evaluation of E/C/F/TAF switch followed by ledipasivir-sofosbuvir antiviral HCV therapy in HIV-HCV co-infection
Learn MoreReporting
CTN 288: LHIVE Healthy
Evaluation of web-based interventions to support people living with HIV in the adoption of health behaviours
Learn More
CTN Trials have been approved by the Community Advisory Committee of the Canadian HIV Trials Network and the Network’s Scientific Review Committee, or other national peer-review panels such as those at the Canadian Institutes of Health Research and the U.S. National Institutes of Health. CTNPT studies are small-scale investigations designed to determine the feasibility of research concepts, and do not all go through the regular CTN clinical trial review process. For information on the benefits and risks of participating in HIV clinical trials, call CATIE toll-free at 1-800-263-1638.